NDC 31722-301-25 - Eltrombopag

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
31722-301
Requested NDC
31722-301-25
Package NDCs from labels
31722-301-25, 31722-301-31, 31722-301-32
Manufacturer
Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited
Effective date
2025-03-27
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Eltrombopag - Camber Pharmaceuticals, Inc. | Annora Pharma Private LimitedCamber Pharmaceuticals, Inc. | Annora Pharma Private Limited2025-03-27HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
31722-301-25Eltrombopag1 in 1 PACKETPOWDER, FOR SUSPENSION11
31722-301-31Eltrombopag30 in 1 CARTONPOWDER, FOR SUSPENSION301
31722-301-32Eltrombopag1 in 1 KITPOWDER, FOR SUSPENSION11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
31722-301ELTROMBOPAG (ELTROMBOPAG OLAMINE) POWDER, FOR SUSPENSION [CAMBER PHARMACEUTICALS, INC.]1Current NDC, 3 package rows20250514_8f6499f0-4774-4f1e-8ab5-145c1fe64401.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
31722-301-25EA - Each31722-301060a79a5-97f5-4f33-b66b-5f88fd0636f312025-06-13
31722-301-32EA - Each31722-301f601a99e-9699-4e6a-8216-9e5f122c876a12025-06-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 35 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QR PAINANALGESICMARYHELENE ENTERPRISES INC9984a510-30be-4013-e053-2995a90a841e2025-11-14WarningsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLProPharma Distribution430669d7-9ad1-9a04-e063-6394a90ababb2025-11-07Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Sorbitol-MannitolSORBITOL AND MANNITOLICU Medical Inc.5b44e248-4b7b-4777-954a-921c7b3099442025-10-30Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLICU Medical Inc.ba7bf864-8a4d-4262-8fd1-00174fa2f9d12025-10-24Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Eltrombopag OlamineELTROMBOPAGAmneal Pharmaceuticals NY LLC05acf38e-7870-4809-a045-fc38e66b11102025-09-12Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 4U07F515LG
OsmitrolMANNITOLBaxter Healthcare Company0d914965-7001-45cb-ba51-d7c5964b05bc2025-08-26Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
EltrombopagELTROMBOPAGBiocon Pharma Inc.074dbfa7-eadb-e722-0a7a-86a97882f0312025-06-10Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 4U07F515LG
EltrombopagELTROMBOPAG OLAMINECamber Pharmaceuticals, Inc.8f6499f0-4774-4f1e-8ab5-145c1fe644012025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA216620
ndc (package): 31722-300-31
ndc (package): 31722-301-32
ndc (package): 31722-300-32
ndc (package): 31722-301-31
ndc (package): 31722-300-12
ndc (package): 31722-301-25
ndc (product): 31722-301
ndc (product): 31722-300
ndc11 (package): 31722030125
rxcui: 1859498
rxcui: 2058980
spl id: 315730ec-c40c-af1a-e063-6294a90a010f
spl set id: 8f6499f0-4774-4f1e-8ab5-145c1fe64401
unii: 4U07F515LG
Aspartame/MSG DetoxCHELIDONIUM MAJUS, ARNICA MONTANA, PHYTOLACCA DECANDRA, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BISPHENOL A (BPA), DEXTROSE, MALTODEXTRIN, SUCRALOSE, ASPARTIC ACID, DIKETOPIPERAZINE, DOPAMINE HYDROCHLORIDE, FORMALINUM, FORMICUM ACIDUM, L-PHENYLALANINE, METHYL ALCOHOL, MONOSODIUM GLUTAMATEDeseret Biologicals, Inc.a1dc1bf3-db71-4550-a975-4f146fb940052025-03-11WarningsExact identifier
unii: 96K6UQ3ZD4
MANNITOLMANNITOLHF Acquisition Co LLC, DBA HealthFirst999ce711-2d5b-0d7d-e053-2995a90a26892024-01-27Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Anubis BarcelonaDMAEANUBIS COSMETICS SLf22b212d-d21d-5984-e053-2995a90a683e2023-09-01WarningsExact identifier
unii: TTV12P4NEE
Anubis BarcelonaDMAE, ZIRHAFIRMANUBIS COSMETICS SLf2274f8c-08aa-eb02-e053-2a95a90a39982023-09-01WarningsExact identifier
unii: TTV12P4NEE
Anubis BarcelonaPROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOLANUBIS COSMETICS SLebdddcec-f5da-51fe-e053-2995a90a61672023-09-01WarningsExact identifier
unii: TTV12P4NEE
MannitolMANNITOLB. Braun Medical Inc.d12cc802-b538-4065-a264-f474ff3b30432023-08-15Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLFresenius Kabi USA, LLCc395e13d-6ea1-4104-8b37-669cfb982f042023-03-16Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.